375 related articles for article (PubMed ID: 21450901)
1. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
2. Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.
Yang F; Wei Y; Cai Z; Yu L; Jiang L; Zhang C; Yan H; Wang Q; Cao X; Liang T; Wang J
Cell Mol Immunol; 2015 Jan; 12(1):66-76. PubMed ID: 24769795
[TBL] [Abstract][Full Text] [Related]
3. Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).
Ostrand-Rosenberg S; Sinha P; Chornoguz O; Ecker C
Cancer Immunol Immunother; 2012 Aug; 61(8):1319-25. PubMed ID: 22546994
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.
Hu X; Bardhan K; Paschall AV; Yang D; Waller JL; Park MA; Nayak-Kapoor A; Samuel TA; Abrams SI; Liu K
J Biol Chem; 2013 Jun; 288(26):19103-15. PubMed ID: 23677993
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
6. Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer.
Gibson JT; Orlandella RM; Turbitt WJ; Behring M; Manne U; Sorge RE; Norian LA
Front Immunol; 2020; 11():590794. PubMed ID: 33123173
[TBL] [Abstract][Full Text] [Related]
7. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S
Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460
[TBL] [Abstract][Full Text] [Related]
8. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.
Huang JR; Tsai YC; Chang YJ; Wu JC; Hung JT; Lin KH; Wong CH; Yu AL
J Immunol; 2014 Feb; 192(4):1972-81. PubMed ID: 24465013
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
10. E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
Mustafa N; Mitxelena J; Infante A; Zenarruzabeitia O; Eriz A; Iglesias-Ara A; Zubiaga AM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008734
[TBL] [Abstract][Full Text] [Related]
11. Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis.
Chornoguz O; Grmai L; Sinha P; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Mol Cell Proteomics; 2011 Mar; 10(3):M110.002980. PubMed ID: 21191032
[TBL] [Abstract][Full Text] [Related]
12. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
13. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
14. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
[TBL] [Abstract][Full Text] [Related]
15. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
Apolloni E; Bronte V; Mazzoni A; Serafini P; Cabrelle A; Segal DM; Young HA; Zanovello P
J Immunol; 2000 Dec; 165(12):6723-30. PubMed ID: 11120790
[TBL] [Abstract][Full Text] [Related]
16. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
18. Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis.
Kilinc MO; Rowswell-Turner RB; Gu T; Virtuoso LP; Egilmez NK
J Immunol; 2009 Dec; 183(12):7656-60. PubMed ID: 19923444
[TBL] [Abstract][Full Text] [Related]
19. Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens.
Flores-Mendoza G; Rodríguez-Rodríguez N; Rubio RM; Madera-Salcedo IK; Rosetti F; Crispín JC
Front Immunol; 2021; 12():635862. PubMed ID: 33841416
[TBL] [Abstract][Full Text] [Related]
20. A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response.
Chakraborty P; Das S; Banerjee K; Sinha A; Roy S; Chatterjee M; Choudhuri SK
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):165-75. PubMed ID: 24611750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
